The surgical and functional outcome of limb-salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity. 2005

Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Suite 476E, Toronto, Ontario M6B 1H9, Canada.

BACKGROUND This study compared the surgical, oncological, and functional outcomes of patients undergoing limb-salvage surgery for extremity soft tissue sarcoma with vascular resection and reconstruction with the outcomes of those undergoing limb-salvage without vascular reconstruction. METHODS Nineteen patients were identified from a prospective soft-tissue sarcoma database who underwent vascular resection and reconstruction as part of their limb-salvage surgery and who were followed up for at least 1 year or until death. Each of these 19 patients was case-matched to 2 additional patients on the basis of tumor location, size, and depth; patient age; and timing of radiation. To compare functional outcome, a subset of patients was case-matched with additional criteria including wound-complication status, motor nerve sacrifice, similar preoperative function as determined by the Toronto Extremity Salvage Score, and no metastases at diagnosis or the 1-year follow-up. RESULTS Patients in the vascular reconstruction group were more likely to require a muscle transfer (53% vs. 18%; P = .008), experience a wound complication (68% vs. 32%; P = .03), experience deep venous thrombosis (26% vs. 0; P = .003), experience significant limb edema (87% vs. 20%; P = .001), and ultimately require an amputation (16% vs. 3%; P = .07). Patients who underwent vascular reconstruction had only slightly lower Toronto Extremity Salvage Score scores 1 year after surgery (78.5 vs. 84.2; P = .35). There were no significant differences in local or systemic tumor relapse between the two groups. CONCLUSIONS Vascular reconstruction is a feasible option in limb-salvage surgery for soft tissue sarcoma but is associated with an increased risk for postoperative complications, including amputation. Although function is not significantly worse after vascular reconstruction, the results are less predictable.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008080 Liposarcoma A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed) Liposarcoma, Dedifferentiated,Liposarcoma, Pleomorphic,Atypical Lipomatous Tumor,Liposarcoma, Well Differentiated,Well Differentiated Liposarcoma,Atypical Lipomatous Tumors,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcomas,Lipomatous Tumor, Atypical,Liposarcomas,Pleomorphic Liposarcoma,Pleomorphic Liposarcomas,Well Differentiated Liposarcomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas

Related Publications

Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
October 1998, Plastic and reconstructive surgery,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
January 2017, Journal of vascular surgery,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
September 2008, Journal of the Egyptian National Cancer Institute,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
April 2000, Journal of surgical oncology,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
March 2008, Journal of surgical oncology,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
October 1996, Archives of surgery (Chicago, Ill. : 1960),
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
December 2003, Current treatment options in oncology,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
June 1987, Surgery,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
May 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS,
Michelle A Ghert, and Aileen M Davis, and Anthony M Griffin, and Ali H Alyami, and Lawrence White, and Rita A Kandel, and Peter Ferguson, and Brian O'Sullivan, and Charles N Catton, and Thomas Lindsay, and Barry Rubin, and Robert S Bell, and Jay S Wunder
August 1984, Radiology,
Copied contents to your clipboard!